NASDAQ · Drug Manufacturers - Specialty & Generic
InMed Pharmaceuticals Inc (INM)
$15.56
+17.79%
54
In band
Moving averages
SMA 200$1.18+1,218.64%
Company profile
InMed Pharmaceuticals Inc., a clinical-stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company is headquartered in Vancouver, Canada.
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market cap$7.47M
P/E ratioNone
EPS$-2.84
Beta0.928
Dividend yield0.00%
52-week high$2.33
52-week low$0.58
Similar stocks in Drug Manufacturers - Specialty & Generic
HIMS
Hims & Hers Health Inc - Class A
RSI 27
CGC
Canopy Growth Corporation
RSI 21
BFRI
Biofrontera Inc
RSI 31
TLRY
Tilray Brands Inc - Class 2
RSI 27
ORGO
Organogenesis Holdings Inc - Class A
RSI 38
ACB
Aurora Cannabis Inc
RSI 45
BCRX
Biocryst Pharmaceuticals Inc
RSI 37
LNTH
Lantheus Holdings Inc
RSI 68
RSI alerts for INM
An email when INM closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 7:15 AM EST